Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: a post-marketing surveillance study.
Bravo L, Chitraka A, Liu A, Choudhury J, Kumar K, Berezo L, Cimafranca L, Chatterjee P, Garg P, Siriwardene P, Bernardo R, Mehta S, Balasubramanian S, Karkada N, Htay Han H.
Bravo L, et al. Among authors: kumar k.
Hum Vaccin Immunother. 2014;10(8):2276-83. doi: 10.4161/hv.29280.
Hum Vaccin Immunother. 2014.
PMID: 25424932
Free PMC article.
Clinical Trial.